Antidepressant Withdrawal: Research-Backed Guidance on Safe Tapering and Discontinuation
By
Amen Clinics
Summary
This article from Amen Clinics discusses the challenges of discontinuing antidepressant medication, emphasizing that withdrawal symptoms are often misdiagnosed as relapse. It cites research showing that over half of antidepressant users experience withdrawal effects, with nearly half of those describing them as severe. The article provides guidance on safe tapering protocols, including very gradual dose reductions (sometimes over months or years) and the use of liquid formulations or compounding pharmacies for precise dosing. It also addresses the controversy around whether these effects constitute "withdrawal" or "discontinuation syndrome," noting that the term "withdrawal" is more accurate based on the severity of symptoms reported in studies.
Source

Key quotes
· 3 pulledOver half (56%) of people who attempt to come off antidepressants experience withdrawal effects, and nearly half (46%) of those describe these effects as severe.
The term 'discontinuation syndrome' was introduced by the pharmaceutical industry to downplay the risks of stopping antidepressants, but the evidence shows that 'withdrawal' is a more accurate description.
A slow, gradual taper — sometimes over many months or even years — can significantly reduce the severity of withdrawal symptoms.
You might also wanna read
RFK Jr.'s Campaign to Deprescribe Antidepressants Enters Federal Health Policy Debate
This article examines Robert F. Kennedy Jr.'s latest public health campaign focused on "deprescribing" — the process of helping patients tap
Research Links Depression to Reduced Ability to Learn Active Avoidance Behaviors in Young Adults
This research article presents findings from two studies examining the relationship between depressive symptoms and avoidance behaviors in y
eneuro.org·9mo agoWhat Happens When You Stop Taking GLP-1 Weight Loss Medications
This article examines the experiences of people who stop taking GLP-1 weight loss medications (like Ozempic and Wegovy), exploring what happ
Study: Stopping GLP-1 Drugs Increases Heart Attack and Stroke Risk
New research published in BMJ Medicine reveals that stopping GLP-1 drugs (originally for diabetes, now popular for weight loss) leads to a r
nautil.us·3mo agoAnalytical Review: Finasteride's Link to Depression and Suicidality
This analytical review examines the serious neuropsychiatric side effects of finasteride, a drug commonly used for hair loss treatment. The

Systematic Review Ranks Efficacy and Acceptability of Antipsychotics for Major Depressive Disorder
This systematic review and network meta-analysis compares FDA-approved atypical antipsychotics used as adjunctive treatment for major depres

Comments
Sign in to join the conversation.
No comments yet. Be the first.